ImmunoCellular To Present Encouraging Phase 1 Study Results For Brain Tumour Treatment

ImmunoCellular Therapeutics will present positive results from a phase 1 clinical study on its ICT-107 therapy, a treatment for a type of brain tumor.

Read more »

Access Pharmaceuticals Inks Deal To Expand MuGard Distribution

Access Pharmaceuticals announced Tuesday it has signed an agreement with eMax Health Systems to expand the distribution of the company’s MuGard treatment.

Read more »

Valeant Pharmaceuticals to acquire Lithuania’s Sanitas for $442m

Valeant Pharmaceuticals said Tuesday that it agreed to buy Lithuania-based generic drug company Sanitas for €314 million in cash.

Read more »

NeoStem’s Suzhou Erye Receives 2 Pharma Industry Awards, Positioned For Future Growth

NeoStem announced Tuesday that Chinese generic pharma company Suzhou Erye, in which it owns a 51% majority stake, has won two awards at the 2011 Chempharm Brand Summit.

Read more »